Home › Funds › DEERFIELD MANAGEMENT COMPANY, L.P. › TNGX

DEERFIELD MANAGEMENT COMPANY, L.P. position in TNGX

TANGO THERAPEUTICS INC · Health Care

DEERFIELD MANAGEMENT COMPANY, L.P. reported holding 5,180,000 shares of TNGX (TANGO THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$129.2M, representing 2.59% of its reported portfolio and ranking #10 among its reported holdings. DEERFIELD MANAGEMENT COMPANY, L.P. has disclosed TNGX holdings in 9 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)5.18M sh
Reported value held$129.24M
Portfolio Weight2.59%
First reportedQ3 2023
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How DEERFIELD MANAGEMENT COMPANY, L.P.'s TNGX position evolved

DEERFIELD MANAGEMENT COMPANY, L.P. first disclosed a stake in TNGX in Q3 2023 at 793,729 shares (US$8.9M). The position peaked in Q2 2026 at 4,190,611 shares, worth US$131.0M. Across 9 filings, DEERFIELD MANAGEMENT COMPANY, L.P. increased the stake 4 time(s), trimmed it 0 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 5,180,000 shares valued at US$129.2M — an increase of 989,389 shares quarter over quarter.. Notable position changes include a 94% increase in Q4 2023 (shares fell 20% over the following quarter), a 43% increase in Q1 2026 (shares rose 49% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 793.73K $8.94M New
Q4 2023 1.54M $15.25M Add
Q1 2024 1.54M $12.23M Hold
Q2 2024 1.54M $13.21M Hold
Q3 2024 1.54M $11.86M Hold
Q4 2025 2.91M $25.76M New
Q1 2026 4.15M $86.75M Add
Q2 2026 4.19M $131.00M Add
Q3 2026 5.18M $129.24M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TNGX and 13F data

TNGX (TANGO THERAPEUTICS INC) is a Health Care company. 63 other funds we track also report a position in TNGX — the largest reported positions include Farallon Capital Management (US$383.8M), RTW INVESTMENTS, LP (US$350.5M), Boxer Capital Management, LLC (US$262.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TNGX

All TNGX fund holders →

FAQ

How long has DEERFIELD MANAGEMENT COMPANY, L.P. held TNGX?

DEERFIELD MANAGEMENT COMPANY, L.P. has disclosed TNGX holdings in 9 of the last 13 reported quarters, going back to Q3 2023.

What is DEERFIELD MANAGEMENT COMPANY, L.P.'s current position in TNGX?

As of Q3 2026, DEERFIELD MANAGEMENT COMPANY, L.P. holds 5.18M shares of TNGX (TANGO THERAPEUTICS INC), valued at $129.24M, representing 2.59% of its reported portfolio and ranking #10.

Has DEERFIELD MANAGEMENT COMPANY, L.P. been buying or selling TNGX?

In the latest 13F filing (Q3 2026), DEERFIELD MANAGEMENT COMPANY, L.P. increased its position in TNGX. The position peaked in Q2 2026 at 4.19M shares.

Which other funds hold TNGX?

Other major institutional holders of TNGX include Farallon Capital Management, RTW INVESTMENTS, LP, Boxer Capital Management, LLC, among 63 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.